Lantheus Holdings (LNTH) Other Working Capital Changes (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Other Working Capital Changes came in at $84000.0 in Q1 2026, down 86.85% year-on-year from $639000.0 in Q1 2025, and down 97.2% on a QoQ basis from $3.0 million in Q4 2025.
Lantheus Holdings (LNTH) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 10 years of Other Working Capital Changes data on file, last reported at $84000.0 in Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 86.85% year-over-year to $84000.0 in Q1 2026; TTM through Mar 2026 was -$309000.0, a 105.68% decrease from a year earlier, with the FY2025 full-year figure at $246000.0, down 95.3% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $84000.0, down from $3.0 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for LNTH reached as high as $11.7 million in Q2 2023 and fell as low as -$11.8 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged $356941.2 across 5 years, with a median of $430000.0 in 2022.
- Across the five-year window, Other Working Capital Changes jumped 828.97% in 2024 and plunged 366.83% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$11.9 million in 2022, then soared by 96.99% to -$359000.0 in 2023, then soared by 828.97% to $2.6 million in 2024, then gained by 14.64% to $3.0 million in 2025, then tumbled by 97.2% to $84000.0 in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $84000.0 in Q1 2026, $3.0 million in Q4 2025, and -$2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 244,000.00 |
| Mar 31, 2026 | 244,000.00 |
| Mar 31, 2026 | 244,000.00 |
| Dec 31, 2025 | -938,000.00 |
| Dec 31, 2025 | -938,000.00 |
| Dec 31, 2025 | -938,000.00 |
| Sep 30, 2025 | 4.43 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 528,000.00 |
| Mar 31, 2025 | 528,000.00 |
| Mar 31, 2025 | 528,000.00 |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Sep 30, 2024 | 1.48 Mn |